Granahan Investment Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Sell |
80,362
-61,858
| -43% | -$2.92M | 0.15% | 113 |
|
|
2025
Q1 | $5.56M | Buy |
142,220
+5,782
| +4% | +$226K | 0.28% | 90 |
|
|
2024
Q4 | $7.39M | Sell |
136,438
-36,196
| -21% | -$1.96M | 0.31% | 83 |
|
|
2024
Q3 | $8.7M | Sell |
172,634
-111,015
| -39% | -$5.6M | 0.34% | 89 |
|
|
2024
Q2 | $12.5M | Buy |
283,649
+67,833
| +31% | +$2.98M | 0.5% | 64 |
|
|
2024
Q1 | $10.8M | Buy |
215,816
+89,044
| +70% | +$4.47M | 0.38% | 78 |
|
|
2023
Q4 | $7.66M | Buy |
126,772
+42,210
| +50% | +$2.55M | 0.25% | 103 |
|
|
2023
Q3 | $4.82M | Buy |
84,562
+12,628
| +18% | +$720K | 0.17% | 128 |
|
|
2023
Q2 | $3.67M | Sell |
71,934
-1,703
| -2% | -$86.9K | 0.11% | 141 |
|
|
2023
Q1 | $1.58M | Buy |
+73,637
| New | +$1.58M | 0.05% | 157 |
|